[1] Chlebowski RT, Anderson GL, Aragaki AK,et al.Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the women's health initiative randomized clinical trials[J]. JAMA,2020, 324(4): 369-380. [2] Katsura C, Ogunmwonyi I, Kankam HK, et al.Breast cancer: Presentation, investigation and management[J]. Br J Hosp Med (Lond), 2022, 83(2): 1-7. [3] Sung H, Ferlay J, Siegel RL, et al.Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. [4] 张蒙,崔永春,王春平,等.1990—2019年中国女性乳腺癌疾病负担及其危险因素变化趋势分析[J].中华肿瘤防治杂志,2022,29(7):456-462. [5] 阳红, 查红, 裴柯平. 国际疾病分类(ICD-10)的应用[J]. 西南国防医药, 2004,1(1):89-90. [6] GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019BD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: A systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet,2020 ,396(10258):1204-1222. [7] Chien LH, Tseng TJ, Chen CH, et al.Comparison of annual percentage change in breast cancer incidence rate between Taiwan and the United States-A smoothed Lexis diagram approach[J]. Cancer Med, 2017, 6(7): 1762-1775. [8] 陈万青, 郑荣寿. 中国女性乳腺癌发病死亡和生存状况[J]. 中国肿瘤临床, 2015,42(13):38-44. [9] 陈文婕,董玮琪,乔丽颖,等.2015年内蒙古自治区女性乳腺癌发病与死亡情况及2010—2015年趋势分析[J].中国肿瘤,2020,29(10):736-743. [10] 杨雅平,梁静,胡越,等.中国南方女性乳腺癌筛查“逸仙模式”初步结果分析[J].中国科学:生命科学,2020,50(10):1114-1120. [11] 闵淑慧,胡依,郭芮绮,等.1990—2019年中国女性乳腺癌疾病负担及变化趋势分析[J].现代预防医学,2021,48(16):2941-2945,2956. [12] 李杰, 张雪, 李道娟,等. 2011—2015年河北省肿瘤登记地区女性乳腺癌发病死亡分析[J]. 肿瘤预防与治疗,2019,8(11):962-968. [13] 朱云峰,沈永洲,王乐,等.浙江省海宁市1977—2016年女性乳腺癌发病分析[J].中国肿瘤,2020,29(8):592-595. [14] 马万成,陈文丹,潘丽,等.深圳市罗湖区2008—2017年恶性肿瘤发病特征及趋势分析[J].中国慢性病预防与控制,2019,27(12):952-956. [15] 苏闪闪,郑蔚,康婷婷,等.康复期老年乳腺癌患者疏离感现状及影响因素分析[J].解放军护理杂志,2021,38(8):34-37. [16] Goetz MP, Okera M, Wildiers H,et al.Safety and efficacy of abemaciclib plus endocrine therapy in older patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer: An age-specific subgroup analysis of MONARCH 2 and 3 trials[J]. Breast Cancer Res Treat, 2021,186(2):417-428. [17] 宋玉娟,刘胜,刘美华,等.乳腺癌早期筛查应用乳腺超声的漏诊、误诊病例特征及相关危险因素分析[J].影像科学与光化学,2021,39(5):736-740. [18] De Groot S, Lugtenberg RT, Cohen D,et al.Fasting mimicking diet as an adjunct to neoadjuvant chemotherapy for breast cancer in the multicentre randomized phase 2 DIRECT trial[J]. Nat Commun,2020,11(1):3083. [19] Montagnese C, Porciello G, Vitale S, et al.Quality of Life in women diagnosed with breast cancer after a 12-month treatment of lifestyle modifications[J]. Nutrients, 2020,13(1):136. |